drugset / Trial / NCT04611529

Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.

NCT04611529

Phase 4 Completed 198 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind placebo-controlled study comparing two different treatments for acute low back pain: oral ibuprofen and topical diclofenac. Participants will be randomized to one of three study arms: 1) Oral ibuprofen + topical diclofenac; 2) Oral ibuprofen + topical placebo; 3) Oral placebo + topical diclofenac. Outcomes will be determined at 48 hours (2 days) and 7 days later.

Timeline

Start
2021-03-02
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 4 g Topical
Subject Ibuprofen Small molecule 400 mg Oral

Indications

No indication recorded.